Follow The Filings

CDNA CareDx

CareDx earnings company data as of 4:45 AM ET 11/1

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.26 — —
Rev $122.0M $139.4M Beat +14.3%

Insider trades

Open-market buys and sales by CDNA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CDNA insider trades
  • None no insider bought on the open market
  • $3.2M sold by 3 insiders outside a trading plan
  • $10.1M sold by 4 insiders under 10b5-1 plans
  1. Jeffrey Adam Novack Secretary and General Counsel
    Planned sale
    $124K 2,688 shares at $46.26 2.5% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  2. Michael Goldberg Director
    Sale
    $2.1M 44,700 shares at $47.06 42% of stake
    Traded Aug 4 Filed Aug 6
    ↗
  3. George Bickerstaff Director
    Sale
    $926K 20,000 shares at $46.29 13% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  4. Christine Cournoyer Director
    Planned sale
    $751K 16,000 shares at $46.94 27% of stake
    Traded Aug 4 Filed Aug 6
    ↗
  5. Hannah Valantine Director
    Planned sale
    $1M 28,779 shares at $36.15 44% of stake
    Traded Jul 16 Filed Jul 17
    ↗
  6. John Walter Hanna Jr. CEO
    Planned sale
    $4.5M 118,000 shares at $37.79 15% of stake
    Traded Jul 16 Filed Jul 17
    ↗
  7. John Walter Hanna Jr. CEO
    Planned sale
    $1.2M 40,000 shares at $29.24 5.7% of stake
    Traded Jun 26–29 Filed Jun 30
    ↗
  8. John Walter Hanna Jr. CEO
    Planned sale
    $425K 17,683 shares at $24.03 2.7% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  9. Hannah Valantine Director
    Planned sale
    $280K 12,103 shares at $23.11 25% of stake
    Traded Jun 15 Filed Jun 16
    ↗
  10. John Walter Hanna Jr. CEO
    Planned sale
    $528K 21,998 shares at $24.02 3.3% of stake
    Traded Jun 11 Filed Jun 15
    ↗
  11. John Walter Hanna Jr. CEO
    Planned sale
    $116K 4,835 shares at $24.00 0.7% of stake
    Traded Jun 4 Filed Jun 8
    ↗
  12. Arthur A Torres Director
    Sale
    $215K 10,570 shares at $20.31 22% of stake
    Traded May 14–15 Filed May 18
    ↗
  13. Jeffrey Adam Novack Secretary and General Counsel
    Planned sale
    $56K 2,688 shares at $20.68 2.3% of stake
    Traded May 5 Filed May 6
    ↗
  14. John Walter Hanna Jr. CEO
    Planned sale
    $217K 10,282 shares at $21.12 1.5% of stake
    Traded Apr 16 Filed Apr 20
    ↗
  15. Jeffrey Adam Novack Secretary and General Counsel
    Planned sale
    $91K 4,441 shares at $20.56 3.4% of stake
    Traded Feb 3 Filed Feb 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 27 share withholdings for taxes, 22 stock grants, and 12 option exercises.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K/A 2.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.01,7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.